ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,749Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 992

$395K Total Retail Price of All Prescriptions

Rank: 64 out of 992

399 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 6,173 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $139 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 4.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 369 324 1 1
AMLODIPINE BESYLATE 308 276 2 10
METFORMIN HCL ER 281 242 3 115
LEVOTHYROXINE SODIUM 261 242 4 17
LOSARTAN POTASSIUM 214 173 5 33
SIMVASTATIN 205 166 6 12
SULFASALAZINE 173 162 7 125
LACTULOSE 159 120 8 38
ALLOPURINOL 158 151 9 71
ATORVASTATIN CALCIUM 156 140 10 19
SINGULAIR 149 144 11 87
NEXIUM 135 133 12 4
FUROSEMIDE 121 121 13 30
ATENOLOL 120 108 14 29
METOPROLOL SUCCINATE 119 110 15 54
SPIRONOLACTONE 114 109 16 72
PANTOPRAZOLE SODIUM 106 105 17 2
LOSARTAN-HYDROCHLOROTHIAZIDE 104 87 18 61
ENALAPRIL MALEATE 103 90 19 152
TRAMADOL HCL 97 83 20 55
SUCRALFATE 90 85 21 15
CREON 85 69 22 16
ACTOS 83 83 23 101
METOPROLOL TARTRATE 81 81 24 52
RANITIDINE HCL 78 77 25 7
AMITRIPTYLINE HCL 77 70 R 26 80
ALENDRONATE SODIUM 77 76 26 31
DEXILANT 74 48 28 5
COLESTIPOL HCL 71 60 29 143
MONTELUKAST SODIUM 68 64 30 132
CIPROFLOXACIN HCL 67 58 31 63
CRESTOR 60 60 32 45
PLAVIX 57 54 33 47
KLOR-CON 8 57 57 33 193
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.